ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle ™ self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur.
| Website | http://www.angany.com |
| Revenue | $2 million |
| Employees | 14 (13 on RocketReach) |
| Founded | 2017 |
| Address | 873 St-jean Qu Ste 200, Québec, Quebec G1R 1R2, CA |
| Phone | +33 2 32 59 05 80 |
| Industry | Pharmaceuticals, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Research, Pharmaceutical, First In Class, Allergy Treatment, Platform Technology, Drug Development, Personalized Medicine, Biotechnology, Immunotherapy, Clinical Trials, Drug Discovery, Life Sciences, Therapeutics, Biopharma, Health Technology, Medical Research, Innovation |
| Competitors | Milan Laser Hair Removal, Ideal Image, LaserAway, Lumenis, MyEllevate®, SkinSpirit, American Laser Skincare, Sofwave, Aesthetica Medical Spa, Smooth Skin +21 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular ANGANY employee's phone or email?
The ANGANY annual revenue was $2 million in 2026.
Guy Tropper is the Co-Founder, Vice-President, Corporate and Medical Affairs of ANGANY.
13 people are employed at ANGANY.
ANGANY is based in Québec, Quebec.
The NAICS codes for ANGANY are [325, 32541, 32, 3254].
The SIC codes for ANGANY are [28, 283].